Related Experiment Video

Updated: Feb 9, 2026

Assessing Working Memory in Children: The Comprehensive Assessment Battery for Children – Working Memory (CABC-WM)
09:05

Assessing Working Memory in Children: The Comprehensive Assessment Battery for Children – Working Memory (CABC-WM)

Published on: June 12, 2017

30.9K

An update on the management of severe idiopathic aplastic anaemia in children

Jeffrey K Davies1, Eva C Guinan

  • 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.

British Journal of Haematology
|January 12, 2007
PubMed

Insights

Outcomes for children with severe idiopathic aplastic anaemia have improved. Allogeneic stem-cell transplantation offers high survival for those with a matched sibling donor, while other treatments are being refined for those without.

Area of Science:

  • Pediatric Hematology
  • Immunology
  • Oncology

Background:

  • Severe idiopathic aplastic anaemia (AA) in children historically had a poor prognosis.
  • Improved diagnostic capabilities now better distinguish idiopathic AA from inherited bone marrow failure syndromes.
  • Significant advancements have enhanced the outlook for pediatric AA patients.

Purpose of the Study:

  • To review the current therapeutic landscape for severe idiopathic aplastic anaemia in children.
  • To discuss the efficacy and challenges of different treatment modalities.
  • To highlight emerging therapies and future directions for improving patient outcomes.

Main Methods:

  • Review of current literature and treatment guidelines for pediatric idiopathic aplastic anaemia.
  • Analysis of outcomes associated with allogeneic haematopoietic stem-cell transplantation (AHSCT) and immunosuppressive therapy (IST).
  • Evaluation of advancements in alternative donor AHSCT and novel therapeutic strategies.

Main Results:

  • Allogeneic haematopoietic stem-cell transplantation (AHSCT) with a human leucocyte antigen (HLA)-matched sibling donor (MSD) achieves ~90% long-term disease-free survival but carries risks of graft-versus-host disease.
  • Combination immunosuppressive therapy (IST) shows response rates >70%, but relapse and transformation to myelodysplasia or acute myeloid leukaemia are significant concerns.
  • Alternative donor AHSCT, enhanced by new technologies, offers a viable option for patients unresponsive to IST, with reduced toxicity and improved outcomes.

Conclusions:

  • The prognosis for children with severe idiopathic aplastic anaemia has markedly improved.
  • AHSCT is the preferred treatment for those with an MSD, while IST is effective but associated with long-term risks.
  • Advances in alternative donor AHSCT and a deeper understanding of AA pathophysiology offer hope for further improvements in treatment efficacy and patient survival.

More Related Videos

Cell-based Assay Protocol for the Prognostic Prediction of Idiopathic Scoliosis Using Cellular Dielectric Spectroscopy08:08

Cell-based Assay Protocol for the Prognostic Prediction of Idiopathic Scoliosis Using Cellular Dielectric Spectroscopy

Published on: October 16, 2013

11.0K
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.5K

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
312
Managing Impressions01:19

Managing Impressions

Impression management encompasses individuals' deliberate efforts to shape how others perceive them during social interactions. This behavior is often employed to conform to social norms, secure approval, or pursue specific goals. While it involves selective self-presentation, it is not necessarily deceptive; individuals frequently present authentic aspects of themselves that align with situational demands.Common strategies include:Ingratiation: where individuals use flattery or agreeableness...
177
Impression Management Techniques I: Managing Appearances01:29

Impression Management Techniques I: Managing Appearances

Appearance is a multidimensional aspect of self-presentation that encompasses observable attributes such as clothing, grooming, speech, and nonverbal behavior. These elements are often strategically managed to align with socially constructed expectations in different settings. For instance, individuals tailor their appearance during job interviews, social gatherings, or athletic events to meet the perceived norms of those environments.Contextual Adaptation and Social SignalsThe research...
220
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
439
Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
666
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
546